Pfizer cuts 6,000 manufacturing jobs; Finland targets illegal imports in online sting;

> Streamlining the combined Wyeth-Pfizer operations--and such accompanying cost cuts as those to be realized by the just announced facility closings and elimination of 6,000 jobs--is a key reason the two companies merged. Item

> Finnish customs officials are investigating illegal drug imports, zeroing in on 800 online orders of medication from abroad placed over a two-month period. Article

> Two non-sterile lots of metronidazole injection, manufactured by Claris Lifesciences and distributed by Sagent, have prompted a nationwide recall. Item

> Medical and surgical equipment distributor Owens & Minor has expanded its scope with the launch of OM HealthCare Logistics, a Louisville, KY-based cGMP-compliant third-party logistics provider offering cold chain management, reverse logistics, repackaging, sample management and kitting. Announcement

> A pharmaceutical manufacturing plant is among the first the U.S. to achieve a newly developed EPA designation for pharmaceutical manufacturing as well as an environmental leadership award. Release

Suggested Articles

South Korea’s Celltrion, which has a massive biologics site in Songdo, has decided it is time to build some operations in China.

WuXi Biologics is taking control of a Bayer plant in Germany and agreed it could serve as a backup facility for supply of hemophilia drug Kovaltry.

A Chinese OTC drugmaker gets the distinction of ringing in the new year as the first company to be slapped with an FDA warning letter.